Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells.

Source:http://linkedlifedata.com/resource/pubmed/id/21383502

J. Clin. Invest. 2011 Apr 1 121 4 1283-97

Download in:

View as

General Info

PMID
21383502